iShares Bitcoin Trust vs 10X Genomics Inc — how do they compare? iShares Bitcoin Trust trades at $36.23, while 10X Genomics Inc trades at $58.61 (market cap $7.64B). The key difference: 10X Genomics Inc is trading nearer its 52-week high, iShares Bitcoin Trust nearer its low. Which is the better fit depends on your goals.
| IBIT | TXG | |
|---|---|---|
Sector | Crypto-linked | Health |
52-Week High | $71.29 | $58.57 |
52-Week Low | $33.29 | $11.34 |
Market Cap | — | $7.64B |
Enterprise Value | — | $7.17B |
Signals from Pluang's Aura AI — not financial advice
IBIT trades at $36.80, up 0.85% today, with a bullish technical signal from moving averages and neutral oscillators. Key support is at $36 and resistance at $37. Recent news highlights strong institutional interest, with BlackRock's head of digital assets noting 'overwhelming demand' for crypto ETFs (Bloomberg, 2026-08-10).
The outlook is cautiously optimistic given technical strength and institutional inflows, but risks include Bitcoin price volatility and regulatory uncertainty. Analyst sentiment is mixed, with some recommending long-term buys amid crypto market downturns.
No Aura AI signal available yet.
Trailing returns across standard periods
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →